Edel A. McNeela

2.7k total citations · 1 hit paper
24 papers, 2.2k citations indexed

About

Edel A. McNeela is a scholar working on Immunology, Microbiology and Molecular Biology. According to data from OpenAlex, Edel A. McNeela has authored 24 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Microbiology and 6 papers in Molecular Biology. Recurrent topics in Edel A. McNeela's work include Immunotherapy and Immune Responses (7 papers), Immune Response and Inflammation (7 papers) and Bacterial Infections and Vaccines (6 papers). Edel A. McNeela is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Immune Response and Inflammation (7 papers) and Bacterial Infections and Vaccines (6 papers). Edel A. McNeela collaborates with scholars based in Ireland, United Kingdom and Canada. Edel A. McNeela's co-authors include Ed C. Lavelle, Kingston H. G. Mills, Sarah Higgins, Rino Rappuoli, Alexander U. Lüthi, Rebecca C. Taylor, Peter Vandenabeele, Sean P. Cullen, Kristof Kersse and Inna S. Afonina and has published in prestigious journals such as Immunity, The Journal of Immunology and Advanced Drug Delivery Reviews.

In The Last Decade

Edel A. McNeela

23 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases

2009 564 citations Alexander U. Lüthi, Sean P. Cullen et al. Immunity profile →

Peers

Countries citing papers authored by Edel A. McNeela

Since Specialization

Citations

This map shows the geographic impact of Edel A. McNeela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edel A. McNeela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edel A. McNeela more than expected).

Fields of papers citing papers by Edel A. McNeela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edel A. McNeela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edel A. McNeela. The network helps show where Edel A. McNeela may publish in the future.

Co-authorship network of co-authors of Edel A. McNeela

This figure shows the co-authorship network connecting the top 25 collaborators of Edel A. McNeela. A scholar is included among the top collaborators of Edel A. McNeela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edel A. McNeela. Edel A. McNeela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence and the Evolving Landscape of Immunopeptidomics 2025 ·PROTEOMICS - CLINICAL APPLICATIONS ·(unknown), Edel A. McNeela, Órla O’Donovan, Sweta Rani, Jai Prakash Mehta	1
2	Circulating Angiogenic and Senescent T Lymphocytes in Ageing and Frailty 2024 ·The Journal of Frailty & Aging ·Thomas Byrne, (unknown), Edel A. McNeela, (unknown), Ronan P. Murphy, Michael Harrison	2
3	Mechanism of miRNAs and miRNA-mRNA Regulatory Networks in Modulating Drug Resistance in HER2-Positive Breast Cancer: An Integrative Bioinformatics Approach 2024 ·Cancers ·(unknown), Edel A. McNeela, Órla O’Donovan, Sweta Rani, Jai Prakash Mehta	0
4	miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review 2023 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), Emmet Jordan, Órla O’Donovan, Edel A. McNeela, Jai Prakash Mehta, Sweta Rani	10
5	Circulating inflammatory biomarker responses in intervention trials in frail and sarcopenic older adults: A systematic review and meta-analysis 2023 ·Experimental Gerontology ·Thomas Byrne, (unknown), (unknown), Edel A. McNeela, Michael Harrison	17
6	A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens 2016 ·Journal of Controlled Release ·Christopher J.H. Davitt, Edel A. McNeela, Stéphanie Longet, Joshua Tobias, (unknown), Craig P. McEntee, Mónica Rosa, Ivan S. Coulter, Jan Holmgren, Ed C. Lavelle	26
7	Targeted Nasal Vaccination Provides Antibody-Independent Protection Against Staphylococcus aureus 2013 ·The Journal of Infectious Diseases ·(unknown), Edel A. McNeela, Alison G. Murphy, Joan A. Geoghegan, Kate M. O’Keeffe, John P. Fox, Kin Ho Chan, (unknown), Nicolas Collin, Timothy J. Foster, Rachel M. McLoughlin, Ed C. Lavelle	40
8	The vaccine adjuvant alum inhibits IL‐12 by promoting PI3 kinase signaling while chitosan does not inhibit IL‐12 and enhances Th1 and Th17 responses 2012 ·European Journal of Immunology ·Andrés Mori, Ewa Oleszycka, Fiona A. Sharp, Michelle M. Coleman, (unknown), Manmohan Singh, Derek T. O’Hagan, Lidia Tajber, Owen I. Corrigan, Edel A. McNeela, Ed C. Lavelle	115
9	Recent Advances in Microparticle and Nanoparticle Delivery Vehicles for Mucosal Vaccination 2011 ·Current topics in microbiology and immunology ·Edel A. McNeela, Ed C. Lavelle	23
10	Pneumolysin Activates the NLRP3 Inflammasome and Promotes Proinflammatory Cytokines Independently of TLR4 2010 ·PLoS Pathogens ·Edel A. McNeela, (unknown), Daniel R. Neill, (unknown), Vitor E. Fernandes, Daniela M. Ferreira, (unknown), (unknown), Rachel M. McLoughlin, Andrés Mori, Barry Moran, Katherine A. Fitzgerald, Jürg Tschopp, Virginie Pétrilli, Peter W. Andrew, Aras Kadioglu, Ed C. Lavelle	289
11	Pneumolysin activates the NLRP3 infl ammasome and promotes proinfl ammatory cytokines independently of TLR4 2010 ·The Journal of the American Medical Association (JAMA) Network (American Medical Association) ·Edel A. McNeela, (unknown)	2
12	Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases breakdown → 2009 ·Immunity ·Alexander U. Lüthi, Sean P. Cullen, Edel A. McNeela, Patrick J. Duriez, Inna S. Afonina, Clare Sheridan, Gabriela Brumatti, Rebecca C. Taylor, Kristof Kersse, Peter Vandenabeele, Ed C. Lavelle, Séamus J. Martin	564
13	Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of theNeisseria meningitidisSerogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan 2005 ·Infection and Immunity ·Zhiming Huo, Ruchi Sinha, Edel A. McNeela, Ray Borrow, Rafaela Giemza, Catherine Cosgrove, Paul T. Heath, Kingston H. G. Mills, Rino Rappuoli, George E. Griffin, D. J. Lewis	44
14	Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation 2003 ·The Journal of Immunology ·Ed C. Lavelle, Edel A. McNeela, Michelle E. Armstrong, Olive Leavy, Sarah Higgins, Kingston H. G. Mills	121
15	Toll-Like Receptor 4-Mediated Innate IL-10 Activates Antigen-Specific Regulatory T Cells and Confers Resistance to Bordetella pertussis by Inhibiting Inflammatory Pathology 2003 ·The Journal of Immunology ·Sarah Higgins, Ed C. Lavelle, (unknown), Brian Keogh, Edel A. McNeela, Patricia Byrne, (unknown), Andrew Jarnicki, Peter McGuirk, Kingston H. G. Mills	211
16	Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan 2003 ·Vaccine ·Edel A. McNeela, Inderjit Jabbal‐Gill, Lisbeth Illum, Mariagrazia Pizza, Rino Rappuoli, Audino Podda, D. J. Lewis, Kingston H. G. Mills	104
17	Mistletoe lectins enhance immune responses to intranasally co‐administered herpes simplex virus glycoprotein D2 2002 ·Immunology ·Ed C. Lavelle, George Grant, Árpád Pusztai, Uwe Pfüller, Olive Leavy, Edel A. McNeela, Kingston H. G. Mills, Derek T. O’Hagan	47
18	Manipulating the immune system: humoral versus cell-mediated immunity 2001 ·Advanced Drug Delivery Reviews ·Edel A. McNeela, Kingston H. G. Mills	80
19	Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity 2000 ·The Journal of Immunology ·Elizabeth J. Ryan, Edel A. McNeela, Mariagrazia Pizza, Rino Rappuoli, Luke O'neill, Kingston H. G. Mills	72
20	A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery 2000 ·Vaccine ·Edel A. McNeela	128

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact